From: Genotyping analysis and 18FDG uptake in breast cancer patients: a preliminary research
SNP | SUVmax | SUVmax | SUVpvc | SUVpvc | ||
---|---|---|---|---|---|---|
p -values* | p -values* | |||||
SLC2A1 (rs841853) | ||||||
GG | GG | 5,771 ± 2,475 | 0,1882 | GG | 5,619 ± 2,309 | 0,1067 |
TG | GT + TT | 8,366 ± 4,293 | GT + TT | 8,303 ± 4,135 | ||
TT | ||||||
SLC2A1 (rs710218) | ||||||
AA | AA | 7,497 ± 4,032 | 0,7988 | AA | 7,074 ± 3,200 | 0,6591 |
AT | AT + TT | 7,901 ± 4,175 | AT + TT | 8,271 ± 4,735 | ||
TT | ||||||
HIF1a (rs11549465) | ||||||
CC | CC | 7,387 ± 3,850 | 0,4861 | CC | 7,214 ± 3,237 | 0,6724 |
CT | CT + TT | 8,848 ± 4,948 | CT + TT | 9,118 ± 6,172 | ||
TT | ||||||
APEX1 (rs1130409) | ||||||
TT | TT | 6,607 ± 3,360 | 0,3388 | TT | 6,412 ± 3,051 | 0,3187 |
TG | TG + GG | 8,229 ± 4,310 | TT + GG | 8,119 ± 4,208 | ||
GG | ||||||
VEGFA (rs3025039) | ||||||
CC | CC | 8,107 ± 4,178 | 0,3875 | CC | 7,997 ± 4,038 | 0,3302 |
CT | CT + TT | 6,205 ± 3,307 | CT + TT | 6,193 ± 3,218 | ||
TT | ||||||
MTHFR (rs1801133) | ||||||
CC | CC | 8,415 ± 5,367 | 0,9292 | CC | 7,687 ± 4,390 | 0,9764 |
CT | CT + TT | 7,444 ± 3,661 | CT + TT | 7,549 ± 3,840 | ||
TT |